Get the Stockscreener App
2.22
3.97%
0.08
Stereotaxis Inc stock is traded at $2.22, with a volume of 306.41K.
It is up +3.97% in the last 24 hours and up +6.46% over the past month.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.
See More
Previous Close:
$2.14
Open:
$2.17
24h Volume:
306.41K
Relative Volume:
0.64
Market Cap:
$207.65M
Revenue:
$25.14M
Net Income/Loss:
$-21.57M
P/E Ratio:
-8.2222
EPS:
-0.27
Net Cash Flow:
$-12.23M
1W Performance:
+1.14%
1M Performance:
+6.46%
6M Performance:
-19.38%
1Y Performance:
+23.61%
1-Day Range:
$2.135
$2.25
1-Week Range:
$2.11
$2.25
52-Week Range:
$1.54
$3.59
Stereotaxis Inc Stock (STXS) Company Profile
Name
Stereotaxis Inc
Sector
Industry
Phone
314-678-6100
Address
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Compare STXS vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STXS
Stereotaxis Inc
|
2.225 | 199.71M | 25.14M | -21.57M | -12.23M | -0.27 |
|
ISRG
Intuitive Surgical Inc
|
500.96 | 176.65B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
171.23 | 49.56B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
83.90 | 40.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
258.36 | 37.63B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
43.28 | 36.02B | 28.43B | 1.16B | 1.26B | 1.4457 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-16-25 | Initiated | Citizens JMP | Mkt Outperform |
| Jan-10-24 | Initiated | ROTH MKM | Buy |
| Jul-12-22 | Initiated | Aegis Capital | Buy |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Jan-05-22 | Initiated | Craig Hallum | Buy |
| Jan-05-22 | Initiated | Loop Capital | Buy |
| May-26-21 | Initiated | Piper Sandler | Overweight |
| Sep-08-20 | Initiated | Northland Capital | Outperform |
| Apr-09-20 | Initiated | Cowen | Outperform |
| Apr-07-20 | Initiated | Lake Street | Buy |
View All
Stereotaxis Inc Stock (STXS) Latest News
Robotic technology shields patients and doctors from radiation, Stereotaxis asserts - Traders Union
Short Interest in Stereotaxis Inc. (NYSEAMERICAN:STXS) Increases By 21.2% - MarketBeat
STXSStereotaxis Reports 2022 First Quarter Financial Results - mx.advfn.com
Form S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments - mx.advfn.com
Stereotaxis, Inc. promotes direct experience of RoboticEP benefits through interactive demonstration - Traders Union
Stereotaxis (STXS) Projected to Release Earnings on Monday - MarketBeat
STXS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Can Stereotaxis Inc. keep up with sector leadersJuly 2025 Final Week & Verified Chart Pattern Trade Signals - mfd.ru
Stereotaxis (NYSEAMERICAN:STXS) Shares Up 2.5%Still a Buy? - MarketBeat
Fed Watch: Does Stereotaxis Inc align with a passive investing strategyQuarterly Profit Report & Risk Controlled Stock Alerts - baoquankhu1.vn
Will Stereotaxis Inc. stock recover after earningsMarket Volume Summary & Safe Entry Trade Reports - mfd.ru
Why Stereotaxis Inc. stock is favored by top institutionsQuarterly Performance Summary & Community Consensus Stock Picks - mfd.ru
Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026 - GlobeNewswire
Robotic surgery firm Stereotaxis to reveal 2025 results March 9 - Stock Titan
Stereotaxis announces launch of electrophysiology program at Klinikum Furth - Yahoo Finance
Will Stereotaxis Inc. stock benefit from sector rotationJuly 2025 Selloffs & Risk Adjusted Buy and Sell Alerts - mfd.ru
Stereotaxis (STXS) Launches Robotic Electrophysiology Program in Germany - GuruFocus
Klinikum Fürth Establishes Leading Robotic Heart Arrhythmia Program - GlobeNewswire
Trade Recap: What are the risks of holding Stereotaxis IncMarket Activity Report & Accurate Trade Setup Notifications - baoquankhu1.vn
Stereotaxis (NYSEAMERICAN:STXS) Stock Price Down 1.6%Here's What Happened - MarketBeat
Stereotaxis Bets On New Catheters To Turn Its Niche Into Growth - Finimize
Stereotaxis Inc Stock (STXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
2.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):